Waverly Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$605K Sell
1,278
-110
-8% -$55.4K ﹤0.01% 995
2025
Q4
$648K Buy
1,388
+516
+59% +$240K 0.01% 903
2025
Q3
$372K Sell
872
-437
-33% -$169K ﹤0.01% 958
2025
Q2
$501K Sell
1,309
-223
-15% -$80.4K 0.01% 793
2025
Q1
$529K Buy
1,532
+71
+5% +$22.8K 0.01% 756
2024
Q4
$439K Buy
+1,461
New +$511K 0.01% 714
2015
Q4
Sell
-376
Closed -$29K 242
2015
Q3
$29K Buy
+376
New +$33.3K 0.02% 205

Other funds holding HCA

Waverly Advisors's HCA Position: Q1 2026 in Review

Waverly Advisors reduced its HCA Healthcare (HCA) stake by 7.9% in Q1 2026, selling an estimated $55.4K and leaving 1,278 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Waverly Advisors first reported a position in HCA in Q3 2015 and has held it in 7 quarters since. The position peaked at $648K in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Waverly Advisors held 1,278 shares of HCA Healthcare worth $605K as of Q1 2026.
  • Waverly Advisors sold 110 HCA Healthcare shares in Q1 2026, an estimated $55.4K.
  • HCA Healthcare made up ﹤0.01% of Waverly Advisors's portfolio in Q1 2026, its #995 holding.
  • Waverly Advisors first reported a position in HCA Healthcare in Q3 2015 and has held it in 7 quarters since.
  • Waverly Advisors's HCA Healthcare position peaked at $648K in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.